Inc. Names Resecurity to Its 2026 List of the Fastest-Growing Private Companies in the Pacific
Companies on the Inc. Regionals: Pacific list had a median growth rate of 94 percent. LOS ANGELES–(BUSINESS WIRE)–Inc., the leading media brand and playbook... Read more.
Inc. Names Resecurity to Its 2026 List of the Fastest-Growing Private Companies in the Pacific
Companies on the Inc. Regionals: Pacific list had a median growth rate of 94 percent. LOS ANGELES–(BUSINESS WIRE)–Inc., the leading media brand and playbook... Read more.
Inc. Names Resecurity to Its 2026 List of the Fastest-Growing Private Companies in the Pacific
Companies on the Inc. Regionals: Pacific list had a median growth rate of 94 percent. LOS ANGELES–(BUSINESS WIRE)–Inc., the leading media brand and playbook... Read more.
LiveBy Local Launches Automated Hyperlocal Marketing Platform for Real Estate Agents, Keeping Agents Top of Mind with Every Contact in Their Database
With 2,000+ agents already in the network and reports hyperlocalized to contact’s specific neighborhood, LiveBy Local turns an agent’s existing database... Read more.
LiveBy Local Launches Automated Hyperlocal Marketing Platform for Real Estate Agents, Keeping Agents Top of Mind with Every Contact in Their Database
With 2,000+ agents already in the network and reports hyperlocalized to contact’s specific neighborhood, LiveBy Local turns an agent’s existing database... Read more.
ITA Group Deepens Support of Ownership Works Through Premier Sponsorship of CEO & Executive Convening
WEST DES MOINES, Iowa–(BUSINESS WIRE)–ITA Group, a 100% employee-owned global engagement agency, has been named a Premier Sponsor of the Ownership Works... Read more.
Wenger and Extru-Tech Unite Under JBT Marel at Petfood Forum 2026
Combined Brands Expand Capabilities; Unveil New Minimally Processed Pet Food Lines KANSAS CITY, Mo.–(BUSINESS WIRE)–Wenger and Extru-Tech, both global... Read more.
Corcept to Present New Data from Pivotal Phase 3 ROSELLA Trial of Lifyorli™ (Relacorilant) in Patients with Platinum-Resistant Ovarian Cancer at ASCO 2026
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development... Read more.
Corcept to Present New Data from Pivotal Phase 3 ROSELLA Trial of Lifyorli™ (Relacorilant) in Patients with Platinum-Resistant Ovarian Cancer at ASCO 2026
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development... Read more.
Corcept to Present New Data from Pivotal Phase 3 ROSELLA Trial of Lifyorli™ (Relacorilant) in Patients with Platinum-Resistant Ovarian Cancer at ASCO 2026
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development... Read more.